Anti-Microbial Savior BioteQ Co., Ltd (6864.TWO)
TWD 85.1
(8.41%)
TWD 85.1
(8.41%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 6.99 Million TWD | -28.41% |
| 2022 | 9.76 Million TWD | -43.31% |
| 2021 | 17.23 Million TWD | 168.31% |
| 2020 | 6.42 Million TWD | 12.84% |
| 2019 | 5.69 Million TWD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q2 | 6.51 Million TWD | -6.79% |
| 2023 FY | 6.99 Million TWD | -28.41% |
| 2023 Q4 | 6.99 Million TWD | 13.91% |
| 2023 Q2 | 6.14 Million TWD | -37.15% |
| 2022 Q4 | 9.76 Million TWD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| SYN-TECH Chem. & Pharm. Co., Ltd. | 583.48 Million TWD | 98.801% |
| Level Biotechnology Inc. | 273.2 Million TWD | 97.44% |
| Sagittarius Life Science Corp | 137.82 Million TWD | 94.925% |
| NeoCore Technology Co., Ltd. | 197.47 Million TWD | 96.458% |
| TaiMed Biologics Inc. | 1.32 Billion TWD | 99.473% |
| GlycoNex Incorporation | 276.39 Million TWD | 97.47% |
| VBI | 21.25 Million TWD | 67.089% |
| GeneReach Biotechnology Corp. | 313.7 Million TWD | 97.771% |
| Taiwan Advance Bio-Pharmaceutical Inc. | 514.65 Million TWD | 98.641% |
| Visgeneer Inc. | 185.6 Million TWD | 96.232% |
| Mycenax Biotech Inc. | 1.32 Billion TWD | 99.471% |
| Sunmax Biotechnology Co., Ltd. | 732.98 Million TWD | 99.046% |
| G&E Herbal Biotechnology Co., Ltd. | 119.86 Million TWD | 94.165% |
| Medigen Vaccine Biologics Corporation | 2.24 Billion TWD | 99.689% |
| TaiwanJ Pharmaceuticals Co., Ltd. | 6.61 Million TWD | -5.681% |
| Enimmune corporation | 173.46 Million TWD | 95.968% |
| TaiRx, Inc. | 60.62 Million TWD | 88.464% |
| CHO Pharma, Inc. | 110.83 Million TWD | 93.69% |
| EirGenix Inc. | 1.14 Billion TWD | 99.389% |
| BioLASCO Taiwan Co., Ltd. | 111.98 Million TWD | 93.754% |
| Sunny Pharmtech Inc. | 512.43 Million TWD | 98.635% |
| Lin BioScience, Inc. | 167.73 Million TWD | 95.83% |
| BioGend Therapeutics Co., Ltd. | 93.71 Million TWD | 92.537% |
| Feng Chi Biotech Corp. | 63.03 Million TWD | 88.904% |
| Bio Preventive Medicine Corp. | 124.72 Million TWD | 94.393% |
| Lukas Biomedical Inc. | 161.05 Million TWD | 95.657% |
| RBC Bioscience Corporation | 513.08 Million TWD | 98.637% |
| BiOptic Inc. | 170.56 Million TWD | 95.899% |
| BRIM Biotechnology, Inc. | 42.15 Million TWD | 83.41% |
| Shine-On BioMedical Co.,Ltd. | 23.25 Million TWD | 69.925% |
| Great Novel Therapeutics Biotech & Medicals | 26.81 Million TWD | 73.916% |
| Syngen Biotech Co.,Ltd. | 974.63 Million TWD | 99.282% |
| SynCore Biotechnology Co.,Ltd | 21.22 Million TWD | 67.05% |
| Genomics BioSci & Tech. Co.,Ltd. | 368.33 Million TWD | 98.101% |
| Neith Corporation | 17.43 Million TWD | 59.881% |
| Advagene Biopharma Co., Ltd. | 7.97 Million TWD | 12.268% |
| NaviFUS Corp. | 53.4 Million TWD | 86.903% |
| Gwo Xi Stem Cell Applied Technology Co. , Ltd | 481.48 Million TWD | 98.547% |
| Sinew Pharma Inc. | 39.71 Million TWD | 82.389% |
| Andros Pharmaceuticals Co.,Ltd | 58.03 Million TWD | 87.949% |
| Greenyn Biotechnology Co., Ltd | 364.47 Million TWD | 98.081% |
| Lumosa Therapeutics Co., Ltd. | 227.69 Million TWD | 96.928% |
| AP Biosciences Inc | 106.65 Million TWD | 93.442% |
| Medigen Biotechnology Corp. | 3.53 Billion TWD | 99.802% |
| 3D Global Biotech Inc. | 30.68 Million TWD | 77.204% |
| Pharmosa Biopharm Inc. | 195.99 Million TWD | 96.431% |
| Intech Biopharm Corporation | 1.54 Billion TWD | 99.547% |
| Oneness Biotech Co., Ltd. | 866.42 Million TWD | 99.193% |
| Eusol Biotech Co.,Ltd. | 9.27 Million TWD | 24.601% |
| TWi Biotechnology, Inc. | 55.81 Million TWD | 87.469% |
| Ever Supreme Bio Technology Co., Ltd | 232.95 Million TWD | 96.998% |
| TCI GENE Inc. | 155.54 Million TWD | 95.504% |
| MegaPro Biomedical Co., Ltd | 25.5 Million TWD | 72.581% |
| Senhwa Biosciences, Inc. | 46.17 Million TWD | 84.853% |
| Taiwan Bio Therapeutics Co., Ltd | 328.47 Million TWD | 97.871% |
| NatureWise Biotech & Medicals Corporation | 64.88 Million TWD | 89.221% |
| PharmaEngine, Inc. | 91 Million TWD | 92.315% |
| Savior Lifetec Corporation | 457.95 Million TWD | 98.473% |
| TaiGen Biopharmaceuticals Holdings Limited | 110.94 Million TWD | 93.696% |
| OBI Pharma, Inc. | 650.44 Million TWD | 98.925% |
| Meribank Biotech Co., Ltd | 390.81 Million TWD | 98.21% |
| Acepodia, Inc. | 384.47 Million TWD | 98.181% |
| Caliway Biopharmaceuticals Co., Ltd. | 85.55 Million TWD | 91.825% |